Brief Report - (2025) Volume 12, Issue 3
Received: 02-Jun-2025, Manuscript No. jpd-26-183911;
Editor assigned: 04-Jun-2025, Pre QC No. P-183911;
Reviewed: 18-Jun-2025, QC No. Q-183911;
Revised: 23-Jun-2025, Manuscript No. R-183911;
Published:
30-Jun-2025
, DOI: 10.37421/2684-4281.2025.12.519
Citation: Santis, Marco De. ”Pediatric Dermatology: Advancements in Childhood Skin Care.” J Dermatol Dis 12 (2025):519.
Copyright: © 2025 Santis D. Marco This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Pediatric dermatology encompasses a broad array of skin conditions affecting children, from common ailments like eczema and acne to less frequent genetic disorders. The management of these conditions often involves a combination of topical therapies, systemic medications, and phototherapy. There is an increasing focus on developing personalized treatment plans, acknowledging the unique and evolving nature of the skin barrier function in infants and young children. Consequently, early diagnosis and meticulously tailored interventions are paramount for enhancing long-term health outcomes and the overall quality of life for pediatric patients [1].
Atopic dermatitis (AD), a chronic and recurring inflammatory skin disease, is particularly prevalent in pediatric populations. Recent scientific advancements have significantly improved our understanding of the intricate interplay between genetic predispositions, immune system responses, and environmental triggers. Current therapeutic strategies go beyond traditional emollients and corticosteroids, incorporating novel biologics and Janus kinase (JAK) inhibitors, especially for children with moderate to severe manifestations of the disease [2].
Pediatric acne vulgaris, while frequently perceived as a cosmetic concern, can exert considerable psychological distress on affected children. Current clinical guidelines advocate for a structured, stepwise approach to treatment. This typically begins with topical agents and progresses to oral antibiotics, hormonal therapies, and isotretinoin for cases that are resistant to conventional treatments or present in severe forms. Ongoing research is exploring the role of the skin microbiome and the development of new topical formulations [3].
Viral exanthems are a common occurrence in childhood, often characterized by a variety of skin rashes. A critical aspect of clinical management involves distinguishing between benign viral illnesses and more serious conditions that necessitate specific therapeutic interventions. While most viral exanthems are managed with supportive care, a thorough understanding of diagnostic indicators for specific viral infections, such as varicella, measles, and parvovirus B19, is essential for appropriate clinical decision-making [4].
Birthmarks, including hemangiomas and congenital nevi, require careful dermatological evaluation in pediatric patients. Although many of these lesions regress spontaneously, certain types may necessitate medical or surgical intervention due to their size, anatomical location, or potential to cause complications. The therapeutic landscape for infantile hemangiomas has been significantly transformed by the introduction of beta-blocker medications, while surgical approaches remain important for the management of specific congenital nevi [5].
Fungal infections, such as tinea capitis (ringworm of the scalp) and tinea corporis (ringworm of the body), are frequently encountered in pediatric dermatology. While diagnosis is often based on clinical presentation, mycological confirmation is crucial for guiding effective treatment strategies. Systemic antifungal agents are frequently required for tinea capitis, with griseofulvin and terbinafine being commonly prescribed. Ensuring patient adherence to the prescribed duration of therapy is critical for achieving successful eradication of the infection [6].
Psoriasis in childhood, although less common than in adults, presents unique clinical challenges and can significantly impact a child's overall well-being. The manifestation of psoriasis in children can differ from adult presentations, and treatment approaches are often adapted from adult guidelines, with a strong emphasis on safety and efficacy. Therapeutic strategies include topical agents, phototherapy, and newer systemic therapies like biologics [7].
Infantile seborrheic dermatitis, commonly referred to as cradle cap, is typically a benign and self-limiting condition. While often mild in presentation, more persistent or widespread forms can occur, requiring therapeutic consideration. Management is generally conservative, involving gentle cleansing and the application of emollients. However, in some instances, mild topical corticosteroids or antifungal agents may be necessary [8].
Bacterial skin infections, such as impetigo and cellulitis, are frequent occurrences in pediatric populations and demand prompt recognition. Appropriate antibiotic therapy is essential to prevent the development of serious complications. Consideration of local antibiotic resistance patterns and the judicious use of antimicrobial agents are important aspects of effective treatment [9].
Genetic skin disorders, including ichthyosis and epidermolysis bullosa, pose significant challenges within pediatric dermatology. These complex conditions necessitate multidisciplinary care and often require specialized supportive measures. While advances in genetic research are enabling the development of targeted therapies, the current management primarily focuses on maintaining skin barrier integrity and preventing infections [10].
Pediatric dermatology is a specialized field dedicated to addressing the diverse spectrum of skin conditions encountered in children, ranging from common issues such as eczema and acne to rarer genetic disorders. The management of these conditions is multifaceted, frequently involving a combination of topical treatments, systemic medications, and phototherapy. A growing emphasis is placed on the development of personalized treatment plans, recognizing the dynamic nature of the skin barrier in infants and children. Consequently, the early identification of skin conditions and the implementation of tailored interventions are crucial for improving long-term health outcomes and enhancing the quality of life for young patients [1].
Atopic dermatitis (AD) stands out as a chronic and relapsing inflammatory skin disease that is frequently observed in pediatric age groups. Recent scientific progress has greatly advanced our comprehension of the complex interplay between genetic factors, immune system dysregulation, and environmental influences. The current therapeutic landscape has evolved beyond traditional emollients and corticosteroids to include novel biologics and Janus kinase (JAK) inhibitors, offering targeted treatment options, particularly for moderate to severe cases of AD [2].
Pediatric acne vulgaris, though often viewed as a cosmetic concern, can have a profound and significant psychological impact on affected children. Current treatment guidelines recommend a stepwise therapeutic approach, initiating with topical agents and escalating to oral antibiotics, hormonal therapies, and isotretinoin for cases that are recalcitrant to standard treatments or present with severe symptoms. Research efforts are actively exploring the role of the skin microbiome and the development of innovative topical formulations [3].
Viral exanthems represent a common presentation in childhood, characterized by a wide variety of skin rashes. A key aspect of clinical management involves the ability to differentiate between benign viral illnesses and more severe conditions that require specific therapeutic interventions. While most viral exanthems are managed conservatively with supportive care, a solid understanding of the diagnostic clues for specific viral infections, such as varicella, measles, and parvovirus B19, is vital for appropriate clinical decision-making [4].
Birthmarks, encompassing conditions like hemangiomas and congenital nevi, necessitate careful evaluation within the realm of pediatric dermatology. While many of these lesions tend to resolve spontaneously, certain types may require intervention due to their size, location, or the potential for complications. The management of infantile hemangiomas has been notably transformed by the efficacy of beta-blocker therapy, whereas surgical interventions remain important for specific types of congenital nevi [5].
Fungal infections are prevalent among children, with conditions such as tinea capitis and tinea corporis being commonly encountered. Although diagnosis is often clinical, mycological confirmation plays an important role in guiding appropriate treatment. Systemic antifungal medications are frequently required for tinea capitis, with griseofulvin and terbinafine being standard choices. Ensuring patient adherence to the full course of therapy is paramount for successful eradication of the infection [6].
Psoriasis in childhood, while less common than in adults, presents distinct challenges and can have a substantial impact on a child's overall well-being. Pediatric psoriasis can manifest with varied clinical patterns, and treatment strategies are adapted from adult guidelines, prioritizing both safety and efficacy. Therapeutic modalities include topical agents, phototherapy, and newer systemic therapies such as biologics [7].
Infantile seborrheic dermatitis, commonly known as cradle cap, is typically a benign and self-limiting condition. While generally mild, more persistent or widespread forms can occur and may require therapeutic management. Treatment is usually conservative, involving gentle cleansing and the application of emollients, although mild topical corticosteroids or antifungal agents may sometimes be indicated [8].
Bacterial skin infections, including impetigo and cellulitis, are frequent in pediatric populations and require prompt recognition and management. Early and appropriate antibiotic therapy is crucial to prevent the development of potential complications. Key considerations in treatment include an awareness of local antibiotic resistance patterns and the judicious use of antimicrobial agents [9].
Genetic skin disorders, such as ichthyosis and epidermolysis bullosa, represent a significant area of concern in pediatric dermatology. These conditions demand a multidisciplinary approach to care and often involve specialized supportive measures. Ongoing advances in genetic understanding are paving the way for targeted therapies, although current management largely concentrates on skin barrier repair and the prevention of infections [10].
Pediatric dermatology addresses a wide range of skin conditions in children, from common issues like eczema and acne to rarer genetic disorders. Management strategies are evolving with an emphasis on personalized care and understanding the pediatric skin barrier. Advancements have led to novel treatments for conditions like atopic dermatitis, including biologics and JAK inhibitors. Pediatric acne treatment follows a stepwise approach, with ongoing research into new therapies. Viral exanthems are common, requiring careful differentiation from more serious conditions. Birthmarks like hemangiomas and nevi are evaluated, with beta-blockers revolutionizing infantile hemangioma treatment. Fungal infections such as tinea capitis necessitate systemic antifungals, and adherence to treatment is key. Childhood psoriasis presents unique challenges, with adapted treatment plans prioritizing safety. Infantile seborrheic dermatitis is usually benign, treated conservatively. Bacterial skin infections like impetigo and cellulitis require prompt antibiotic therapy. Genetic skin disorders, including ichthyosis and epidermolysis bullosa, demand multidisciplinary care and focus on skin barrier support and infection prevention.
None
None
Journal of Dermatology and Dermatologic Diseases received 4 citations as per Google Scholar report
